Product
LY3819253
3 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 IllnessStatus: Completed, Estimated PCD: 2023-02-21
Clinical trial
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19 (Trial H1: LY3819253 (LY-CoV555))Status: Completed, Estimated PCD: 2021-02-01
Clinical trial
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19Status: Completed, Estimated PCD: 2022-04-06